neelima denduluri, md, on how the aphinity study could impact treatment of adjuvant breast cancer
Published 7 years ago • 235 plays • Length 1:46
Download video MP4
Download video MP3
Similar videos
-
2:27
debu tripathy, md, on how the aphinity study could impact treatment of adjuvant breast cancer
-
2:07
neelima denduluri, md, describes how cdk 4/6 inhibitors impact breast cancer treatment
-
33:30
neelima denduluri, md -- treatment of triple negative breast cancer
-
1:30
neelima denduluri, md, offers opinion on the persephone trial in early her2 breast cancer
-
1:42
dr. denduluri on the role of neoadjuvant therapy in her2 breast cancer
-
54:12
optune
-
7:57
lung cancer: what you need to know
-
5:41
what does her2 positive mean
-
1:12
neelima denduluri, md, regarding the embraca trial in her2- metastatic breast cancer
-
2:48
neelima denduluri, md, tells us about the recent updates to breast cancer guidelines
-
0:53
neelima denduluri, md, on the monaleesa-3 study in hr /her2- advanced breast cancer
-
1:59
neelima denduluri, md, discusses exciting new approaches to treating breast cancer
-
1:36
neelima denduluri, md, discusses outcomes from the impassion130 trial
-
1:49
neelima denduluri, md, regarding the implications of the tailorx study from asco 2018
-
1:43
neelima denduluri, md, regarding the monaleesa-7 trial in premenopausal metastatic breast cancer
-
1:17
neelima denduluri, md, on the outcomes of the sandpiper study presented at asco 2018
-
1:02
neelima denduluri, md, elaborates on the sophia trial data in her metastatic breast cancer
-
7:30
aphinity trial in her2 breast cancer
-
0:38
neelima denduluri, md, considers whether the results of tailorx are practice-changing
-
1:51
dr. denduluri on treatment approaches in early-stage hr /her2- breast cancer
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
-
55:48
new & supporting data for optimizing therapy in her2 breast cancer | dr. bagegni & dr. gradishar
Clip.africa.com - Privacy-policy